Research Article
Left Atrial Appendage Exclusion in Atrial Fibrillation Radiofrequency Ablation during Mitral Valve Surgery: A Single-Center Experience
Table 2
Efficacy endpoints at discharge and 2-year follow-up.
| | | | Total number | LAA surgical exclusion | No LAA surgical exclusion | value |
| | Total population | At discharge (n; %) | 69 | 37/52 (71.1) | 32/48 (66.6) | 0.628 | | At 2-year follow-up (n; %) | 80 | 44/52 (84.6) | 36/48 (75) | 0.242 |
| | Patients with ML-LAD ≤ 6 cm | At discharge (n; %) | 59 | 29/35 (82.8) | 30/40 (75) | 0.407 | | At 2-year follow-up (n; %) | 69 | 35/35 (100) | 34/40 (85) | 0.017 |
| | Patients with ML-LAD > 6 cm | At discharge (n; %) | 10 | 7/17 (42.2) | 3/8 (37.5) | 0.790 | | At 2-year follow-up (n; %) | 11 | 8/17 (47) | 3/8 (37.5) | 1 |
|
|
LAA: left atrial appendage; ML-LAD: medial lateral left atrium diameter; SR: sinus rhythm. A value < 0.05 was considered statistically significant. |